*Antihemophilic Factor Viii

Records for this ingredient, by country (identity only).

ATC B02BD02 · 2 markets · 14 records

*Antihemophilic Factor Viii 2 markets · 14 records Forms

Filters

MarketCA 11 SG 3

Strength

CA 11 records · 7 shown of 7 Source Health Canada Drug Product Databas · Data as of 2026-10-23

3,000 unitpowderALTUVIIIO+1ESPEROCT
2,000 unitpowderALTUVIIIO+1ESPEROCT
1,000 unitpowderALTUVIIIO+1ESPEROCT
500 unitpowderALTUVIIIO+1ESPEROCT
4,000 unitpowderALTUVIIIO
1,500 unitpowderESPEROCT
250 unitpowderALTUVIIIO

SG 3 records · 3 shown of 3 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

1,000 IU/vial per mL / per unit basis not statedinjectionFANHDI FOR INJECTION 1000 iu/vial
500 IU/vial per mL / per unit basis not statedinjectionFANHDI FOR INJECTION 1000 iu/vial
250 IU/vial per mL / per unit basis not statedinjectionFANHDI FOR INJECTION 1000 iu/vial

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.